The Bionics Institute hosted an online webinar in October 2022 to show how magnetic stimulation of the brain could improve cognition in Alzheimer’s disease.
The Bionics Institute are developing a new treatment to improve memory function in people with Alzheimer’s disease.
Developed by Bionics Institute researcher, Professor Kate Hoy, this new treatment, called Transcranial Magnetic Stimulation (TMS), uses magnetic pulses to alter brain activity.
View a recording of the webinar below to hear:
- Lead research Professor Kate Hoy, explain how magnetic brain stimulation could be key to fighting memory loss in Alzheimer’s disease.
- Clinician Dr Renata Lemke, give an overview of dementia and the limitations of current treatment.
- The personal experience of Cheryl Conway, who is caring for a family member with Alzheimer’s disease.
How TMS aims to help in Alzheimer’s disease
Alzheimer’s disease has been shown to interfere with important networks in the brain and this disruption in neural communication is linked to the cognitive difficulties experienced.
Transcranial Magnetic Stimulation (TMS) aims to improve brain function in people with Alzheimer’s disease by using magnetic pulses to alter brain activity.
This non-invasive approach has shown potential to restore healthy neural network function and improve memory in Alzheimer’s disease.
Our research team now aims to evaluate TMS in a larger clinical sample using a personalised treatment approach.
Event highlights
Professor James Fallon introduces the Bionics Institute.
Cheryl Conway discusses the personal experience of someone who is caring for a family member with Alzheimer’s disease.
Professor Kate Hoy explains how magnetic brain stimulation could be key to fighting memory loss in Alzheimer’s disease.
Clinician Dr Renata Lemke gives an overview of dementia and the limitations of current treatment options.
